# NLR and PLR Levels Following PENG Block in Hip Arthroplasty

> **NCT07023107** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Hip Arthropathy
- Hip Osteoarthritis
- Hip Pain Chronic

## Interventions

- **DRUG:** 0.9% Sodium Chloride Injection
- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT07023107
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-16
- **Primary completion:** 2025-12-09
- **Final completion:** 2025-12-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07023107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07023107, "NLR and PLR Levels Following PENG Block in Hip Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07023107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*